Edwards Lifesciences Corp (EW)

Return on assets (ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	4,174,600	1,402,400	1,521,900	1,503,100	823,400
Total assets	US$ in thousands	13,055,300	9,363,200	8,292,500	8,502,600	7,237,100
ROA		31.98%	14.98%	18.35%	17.68%	11.38%

December 31, 2024 calculation

ROA = Net income ÷ Total assets
= $4,174,600K ÷ $13,055,300K
= 31.98%

The return on assets (ROA) for Edwards Lifesciences Corp has shown a positive trend over the past five years. The ROA was 11.38% as of December 31, 2020, which increased to 17.68% by December 31, 2021. Subsequently, in 2022, the ROA further improved to 18.35%, reflecting the company's ability to generate higher returns relative to its total assets.

In 2023, the ROA slightly declined to 14.98%, which may indicate either a decrease in profitability or an increase in total assets. However, the ROA rebounded significantly in 2024, reaching 31.98%, indicating that the company efficiently utilized its assets to generate substantial returns.

Overall, the upward trend in ROA demonstrates Edwards Lifesciences Corp's effective management of assets to drive profitability and create value for its stakeholders. It showcases the company's ability to generate higher returns relative to the assets employed in its operations, which is a positive indicator of financial performance and efficiency.